Wednesday, January 16, 2013

• Is Celgene's New Rally Sustainable?at Motley Fool (Wed, Jan 16)
• Vertex Pharmaceuticals (VRTX): Today's Featured Drugs Laggardat TheStreet (Wed, Jan 16)

Tuesday, January 15, 2013

• Vertex to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, January 29Business Wire (Tue, Jan 15)
• JPMorgan Healthcare Conference Highlights: Idenix Pharmaceuticalsat Motley Fool (Tue, Jan 15)
• Analyst Moves: LCC, VRTXat Forbes (Tue, Jan 15)

Friday, January 11, 2013

• Vertex Pharmaceuticals Stock Hold Recommendation Reiterated (VRTX)at TheStreet (Fri, Jan 11)

Thursday, January 10, 2013

• JPMorgan Healthcare Conference Highlights: Sarepta Therapeuticsat Motley Fool (Thu, Jan 10)
• Vertex attracts unusual time strategyoptionMONSTER (Thu, Jan 10)

Wednesday, January 9, 2013

• Vertex Refocuses Drug Development to Specialty Diseasesat Bloomberg (Wed, Jan 9)
• The Most Important New Drug of 2012at Motley Fool (Wed, Jan 9)
• Biotech's a Buy, but Hold Off on HMOs: Fund Managerat CNBC (Wed, Jan 9)
• Idenix Says FDA Needs More Time to Review Hold on Hepatitis C Drugat Minyanville (Wed, Jan 9)
• Vertex: The Year Aheadat Motley Fool (Wed, Jan 9)

Tuesday, January 8, 2013

• Vertex Pharmaceuticals (VRTX): Today's Featured Drugs Winnerat TheStreet (Tue, Jan 8)
• Will This Biotech Dominate the Hepatitis-C Market?at Motley Fool (Tue, Jan 8)
• A Conversation With A Breakthrough Drugat Forbes (Tue, Jan 8)

Monday, January 7, 2013

• [video] Stocks Pull Backat CNBC (Mon, Jan 7)
• 3 Health Care Companies I'm Watching Todayat Motley Fool (Mon, Jan 7)

Sunday, January 6, 2013

• This Blockbuster Drug Is Losing Steamat Motley Fool (Sun, Jan 6)
• Vertex Outlines Corporate Strategy and Defines Key 2013 Business PrioritiesBusiness Wire (Sun, Jan 6)

Thursday, January 3, 2013

• The Most Annoying Story in Biotechat Motley Fool (Thu, Jan 3)
• Inside The Pricing Of A $300,000-A-Year Drugat Forbes (Thu, Jan 3)
• Vertex initiated with a Buy at Janney Capitaltheflyonthewall.com (Thu, Jan 3)

Wednesday, January 2, 2013

• AbbVie: Pharma's New Kid on the Blockat Motley Fool (Wed, Jan 2)
• J.P. Morgan: Biotech Stocks Heading Higher in 2013at TheStreet (Wed, Jan 2)

Add VRTX News to My Yahoo!